Bumper Offer - Urjas oil Just @ Rs. 1
Olmin, a prescription drug, is manufactured in various forms such as Tablet. High BP are some of its major therapeutic uses. Olmin also has some secondary and off-label uses. These are listed below.
The optimal dosage of Olmin is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Common side effects of Olmin include Upper respiratory tract infection. Besides the aforementioned side effects, there are other adverse effects of Olmin as well, which are listed below. Normally, these side effects of Olmin are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Olmin is Severe for pregnant women and Mild for women who are breastfeeding. It is important to know if Olmin has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Olmin related warnings section.
Individuals suffering from medical conditions like Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension) must refrain from the use of Olmin since this can cause severe adverse effects. Other conditions have been mentioned below in the Olmin contraindications section.
Additionally, Olmin may also adversely react with other medicines. Refer to the list below for further details.
You should also be aware that Olmin is not safe while driving, and is not addiction.
Olmin is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Olmin is used -
Moderate
Mild
Is the use of Olmin safe for pregnant women?
Pregnant women may get severe side effects after taking Olmin. If you are pregnant, do not take Olmin without a doctor's advice.
Is the use of Olmin safe during breastfeeding?
Side effects of Olmin on breastfeeding women are very mild.
What is the effect of Olmin on the Kidneys?
Olmin may have mild side effects on the kidneys.
What is the effect of Olmin on the Liver?
Olmin has very mild side effects on the liver.
What is the effect of Olmin on the Heart?
Olmin may have mild side effects on the heart. Most people will never see any effect on the heart.
Olmin should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Olmin unless your doctor advises you to do so -
Is this Olmin habit forming or addictive?
No, you will not get addicted to Olmin.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Olmin as you may feel sleepy.
Is it safe?
Yes, but consume Olmin only on doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Olmin for mental disorders.
Interaction between Food and Olmin
When consumed with certain foods, Olmin may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Olmin
Consuming Olmin with alcohol can have many serious effects on your body.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
